Redpoint Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Redpoint Investment Management's RMD Position: Q3 2022 in Review
Redpoint Investment Management reduced its ResMed (RMD) stake by 20% in Q3 2022, selling an estimated $180K and leaving 3,248 shares worth $709K. The position accounts for 0.1% of the portfolio, ranked #250.
Redpoint Investment Management first reported a position in RMD in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.81M in Q2 2020. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.
- Redpoint Investment Management held 3,248 shares of ResMed worth $709K as of Q3 2022.
- Redpoint Investment Management sold 790 ResMed shares in Q3 2022, an estimated $180K.
- ResMed made up 0.1% of Redpoint Investment Management's portfolio in Q3 2022, its #250 holding.
- Redpoint Investment Management first reported a position in ResMed in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's ResMed position peaked at $1.81M in Q2 2020.
- 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.